Financial results - EVOCLINIQ SRL

Financial Summary - Evocliniq Srl
Unique identification code: 36539996
Registration number: J2016012326401
Nace: 8623
Sales - Ron
851.819
Net Profit - Ron
89.645
Employees
12
Open Account
Company Evocliniq Srl with Fiscal Code 36539996 recorded a turnover of 2024 of 851.819, with a net profit of 89.645 and having an average number of employees of 12. The company operates in the field of Activităţi de asistenţă stomatologică having the NACE code 8623.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Evocliniq Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - 831 3.028 4.682 12.173 31.166 40.380 54.626 261.540 851.819
Total Income - EUR - 831 3.028 4.682 12.173 31.166 40.380 54.641 264.198 859.193
Total Expenses - EUR - 0 313 680 672 2.191 12.844 19.716 364.385 746.194
Gross Profit/Loss - EUR - 831 2.715 4.002 11.501 28.976 27.536 34.924 -100.187 113.000
Net Profit/Loss - EUR - 806 2.625 3.862 11.136 28.107 26.349 33.641 -102.829 89.645
Employees - 0 0 0 0 0 0 1 4 12
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 227.5%, from 261.540 euro in the year 2023, to 851.819 euro in 2024. The Net Profit increased by 89.645 euro, from 0 euro in 2023, to 89.645 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Evocliniq Srl

Rating financiar

Financial Rating -
EVOCLINIQ SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Evocliniq Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Evocliniq Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Evocliniq Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Evocliniq Srl - CUI 36539996

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - 0 0 0 0 0 23.832 19.624 141.004 154.780
Current Assets - 876 3.642 7.324 13.863 31.449 23.686 59.042 28.951 142.857
Inventories - 0 0 0 0 0 0 0 0 1.427
Receivables - 0 0 0 0 0 0 1.570 17.384 120.556
Cash - 876 3.642 7.324 13.863 31.449 23.686 57.473 11.567 20.874
Shareholders Funds - 851 3.461 7.259 13.618 30.812 26.397 33.690 -69.241 20.731
Social Capital - 45 44 43 42 41 40 41 40 40
Debts - 25 181 64 245 637 21.120 44.977 246.584 283.266
Income in Advance - 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8623 - 8623"
CAEN Financial Year 8623
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 142.857 euro in 2024 which includes Inventories of 1.427 euro, Receivables of 120.556 euro and cash availability of 20.874 euro.
The company's Equity was valued at 20.731 euro, while total Liabilities amounted to 283.266 euro. Equity increased by 89.585 euro, from -69.241 euro in 2023, to 20.731 in 2024.

Risk Reports Prices

Reviews - Evocliniq Srl

Comments - Evocliniq Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.